Jeffrey Taylor
Cardiovascular Disease · Chicago, ILNPI 1376003913
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,912 of the $8,103 with a category attached, or 85.3%. It is spread thinly across 29 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,627, 3.2 times the $1,140 reported in 2023.
Across 161 payments — averaging $50.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abiomed$2K
- Abbott$763
- Boston Scientific$740
- Edwards Lifesciences$681
- Pfizer$669
- Medtronic$396
- plus $3K from 23 others
What the payments were for
- Travel & lodging$5857%
- Food & beverage$6,91285%
- Education$6067%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abiomed | 19 | $1,766 |
| Abbott | 7 | $763 |
| Boston Scientific | 14 | $740 |
| Edwards Lifesciences | 7 | $681 |
| Pfizer | 25 | $669 |
| Medtronic | 9 | $396 |
| Shockwave Medical, Inc | 12 | $337 |
| Stryker | 4 | $303 |
| Novartis | 12 | $262 |
| Boehringer Ingelheim | 7 | $251 |
| Amgen | 4 | $213 |
| Actelion Pharmaceuticals US, Inc. | 3 | $184 |
| Johnson & Johnson | 7 | $178 |
| Inari Medical, Inc. | 1 | $162 |
| AstraZeneca | 8 | $152 |
| Penumbra, Inc. | 1 | $143 |
| Teleflex LLC | 1 | $137 |
| Sanofi-aventis U.S. LLC | 1 | $124 |
| Esperion Therapeutics, Inc. | 1 | $101 |
| Chiesi USA, Inc. | 2 | $100 |
| E.r. Squibb & Sons, L.L.C. | 4 | $91 |
| Merck | 3 | $60 |
| Bayer | 2 | $55 |
| Lantheus Medical Imaging, Inc. | 2 | $49 |
| BD | 1 | $48 |
| Angiodynamics, Inc. | 1 | $48 |
| Atricure, Inc. | 1 | $36 |
| Cardiva Medical, Inc. | 1 | $34 |
| Bridgebio Pharma, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$996
- ENSITE$522
- SAPIEN 3 Ultra RESILIA$477
- STINGRAY$256
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$182
- FLOWTRIEVER CATHETER, S$162
- CT THROMBECTOMY SYSTEM KIT$162
- FlowTriever$157
- Indigo System$143
- Repatha$141
- TURNPIKE$137
- Diamondback Coronary$136
- UPTRAVI$130
- OPSUMIT$130
- SYMPLICITY G3$125
- VYNDAQEL$109
- NEXLETOL$101
- COREVALVE EVOLUT R$100
How this compares
$8,103 in reported general payments places this provider in the 80th percentile of 932 cardiovascular disease providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $18,211 |
| Losartan Potassium | 22 | $306 |
| Atorvastatin Calcium | 34 | $281 |
| Metoprolol Succinate | 22 | $203 |
| Carvedilol | 12 | $158 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $251 | $18,21111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 932 cardiovascular disease providers in Illinois.
Other cardiovascular disease in Chicago
- Sandeep NathanChicago$892K
- Boaz AvitallChicago$366K
- Akhil NarangChicago$363K
- Michael DavidsonChicago$317K
- Jyothy PuthumanaChicago$269K
- Sanjiv ShahChicago$246K
- Raja MutharasanChicago$146K
- Nitasha SarswatChicago$140K
- Evan SteinChicago$121K
- Dan FintelChicago$119K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.